Sanglad, Lezlie .

HRN: 16-27-74  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2026
CEFUROXIME 500MG (TAB)
04/30/2026
05/06/2026
PO
500mg
1 Tab Bid X 7 Days
Uti
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: